Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000019617-04-000129
Filing Date
2004-02-12
Accepted
2004-02-12 16:04:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 GENELABS TECHNOLOGIES, INC. genelab.htm SC 13G 34463
  Complete submission text file 0000019617-04-000129.txt   36774
Mailing Address 270 PARK AVENUE NEW YORK NY 10017
Business Address 270 PARK AVE 39TH FL NEW YORK NY 10017 2122706000
J P MORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

EIN.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6021 National Commercial Banks

Mailing Address 505 PENOBSCOT DR REDWOOD CITY CA 94063
Business Address 505 PENOBSCOT DR REDWOOD CITY CA 94063 6503969500
GENELABS TECHNOLOGIES INC /CA (Subject) CIK: 0000874443 (see all company filings)

EIN.: 943010150 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42078 | Film No.: 04591727
SIC: 2834 Pharmaceutical Preparations